Enzymology ✅ Molecular Biology ✅ Cells ✅ Carbohydrates ✅ Amino acids & metabolism ✅ Lipids

Reading File
Asking for Preferences

Enzymology Molecular Biology Cells CarbohydratesAmino acids & metabolism LLipids. I completed these topics in biochemistry.% i completed syllabus based on weight of chaoter

Asking for Preferences
Asking for Preferences
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Here are your complete, high-yield MBBS biochemistry revision notes across all 6 topics:

📚 MBBS Biochemistry - High-Yield Revision Notes


1. ENZYMOLOGY

Key Concepts

What is an enzyme?
  • Biological catalysts (mostly proteins; ribozymes are RNA enzymes)
  • Lower the activation energy of a reaction
  • Not consumed in the reaction; highly specific (substrate specificity)
Active site - where substrate binds; made of a few key amino acid residues

Enzyme Kinetics (Michaelis-Menten)

TermMeaning
KmSubstrate concentration at half Vmax; measure of enzyme-substrate affinity (LOW Km = HIGH affinity)
VmaxMaximum reaction velocity when enzyme is saturated
KcatTurnover number - reactions per second per enzyme molecule
  • Lineweaver-Burk plot = double reciprocal (1/V vs 1/[S]); x-intercept = -1/Km, y-intercept = 1/Vmax

Enzyme Inhibition

TypeKmVmaxAntidote example
CompetitiveIncreasesUnchangedEthanol (methanol poisoning)
Non-competitiveUnchangedDecreases-
UncompetitiveDecreasesDecreases-
Irreversible-Decreases permanentlyPralidoxime (organophosphate)
MBBS tip: Competitive inhibitors compete with substrate for the active site; can be overcome by increasing substrate concentration. Non-competitive bind allosteric sites.

Regulation of Enzyme Activity

  1. Allosteric regulation - effector binds non-active site; sigmoidal kinetics (not Michaelis-Menten)
  2. Covalent modification - phosphorylation (kinases) / dephosphorylation (phosphatases)
  3. Zymogen activation - inactive precursors (e.g. trypsinogen → trypsin, pepsinogen → pepsin)
  4. Feedback inhibition - end product inhibits an early enzyme in the pathway

Isoenzymes (High-yield for MBBS)

IsoenzymeSubunitsClinical Use
LDH-1 (H4)Heart↑ in MI (heart and RBC)
LDH-5 (M4)Liver/skeletal muscle↑ in liver disease
CK-MBHeart↑ in MI
CK-MMSkeletal muscle↑ in muscle damage
ALP isoformsBone, liver, intestine↑ in Paget's (bone), cholestasis (liver)

Cofactors & Coenzymes

VitaminCoenzymeEnzyme/Reaction
B1 (Thiamine)TPPPyruvate dehydrogenase, α-KG DH, Transketolase
B2 (Riboflavin)FAD/FMNElectron transfer in ETC
B3 (Niacin)NAD+/NADP+Oxidation-reduction reactions (Krebs, glycolysis)
B5 (Pantothenate)CoAAcyl group transfer
B6 (Pyridoxine)PLPTransamination, decarboxylation
B7 (Biotin)BiotinCarboxylation reactions (ACC, pyruvate carboxylase)
B9 (Folate)THFOne-carbon transfer
B12CobalaminMethylmalonyl-CoA mutase, methionine synthase

2. MOLECULAR BIOLOGY

DNA Structure

  • Double helix; antiparallel strands; base pairing: A=T (2 H-bonds), G≡C (3 H-bonds)
  • B-DNA is physiological form; right-handed helix, 10 bp per turn
  • Chargaff's rule: %A = %T; %G = %C

DNA Replication

  • Semi-conservative (each new DNA has one old + one new strand)
  • Occurs in S phase of cell cycle
  • Origin of replication - starts at AUG (multiple in eukaryotes, one in prokaryotes)
Key Enzymes:
EnzymeFunction
HelicaseUnwinds double helix
PrimaseSynthesizes RNA primer
DNA Pol IIIMain replication enzyme (prokaryotes); adds nucleotides 5'→3'
DNA Pol IRemoves RNA primers, fills gaps
DNA LigaseJoins Okazaki fragments
TopoisomeraseRelieves supercoiling (target of fluoroquinolones)
TelomeraseAdds repeats to chromosome ends (uses RNA template)
  • Leading strand - continuous synthesis (5'→3')
  • Lagging strand - discontinuous Okazaki fragments

Transcription (DNA → RNA)

  • RNA Polymerase II - makes mRNA in eukaryotes
  • Prokaryote RNA Pol - one enzyme for all RNA types
  • Promoter - TATA box (eukaryotes), Pribnow box (prokaryotes)
  • mRNA Processing (eukaryotes): 5' cap (7-methylguanosine) + poly-A tail + splicing of introns
Introns = "In the trash" (removed); Exons = "Expressed"

Translation (mRNA → Protein)

  • Occurs on ribosomes: 80S (60S + 40S) eukaryotes; 70S (50S + 30S) prokaryotes
  • Codons on mRNA; Anticodons on tRNA
  • Start codon: AUG (methionine); Stop codons: UAA, UAG, UGA ("U Are Away", "U Are Gone", "U Go Away")
  • Stages: Initiation → Elongation → Termination
Antibiotic targets on prokaryotic ribosomes:
DrugTargetMnemonic
Aminoglycosides, Tetracyclines30S"Buy AT 30"
Chloramphenicol, Clindamycin, Erythromycin50S"CEL at 50"

Mutations

TypeDescriptionExample
SilentSame amino acid (wobble position)Often C→T at 3rd base
MissenseDifferent amino acidSickle cell (Glu→Val)
NonsensePremature stop codonBeta-thalassemia
FrameshiftInsertion/deletion; shifts reading frameDuchenne MD

DNA Repair

  • Nucleotide excision repair - fixes bulky adducts (UV damage, xeroderma pigmentosum)
  • Base excision repair - fixes small base damage (deamination)
  • Mismatch repair - corrects replication errors (defect → HNPCC/Lynch syndrome)
  • Double-strand break - homologous recombination (accurate) or NHEJ (error-prone)

3. CELLS

Cell Organelles & Functions

OrganelleKey Functions
NucleusDNA storage, transcription
NucleolusrRNA synthesis, ribosome assembly
Rough ERSynthesis of secretory & membrane proteins
Smooth ERLipid synthesis, drug detoxification, Ca2+ storage
Golgi apparatusPost-translational modification, protein sorting/packaging
MitochondriaATP production (Krebs, ETC, β-oxidation); has own DNA (maternal inheritance)
LysosomesIntracellular digestion (acid hydrolases, pH ~5)
Peroxisomesβ-oxidation of very long chain fatty acids; bile acid synthesis
CytoskeletonCell shape, movement, division

Cytoskeleton Components

StructureProteinFunction
MicrofilamentsActinCell movement, cytokinesis
Intermediate filamentsKeratin, vimentin, desmin, GFAPStructural support
MicrotubulesTubulin (α/β)Mitotic spindle, cilia, axonal transport
Cilia - 9+2 arrangement of microtubules; dynein = motor protein. Dynein defect → Kartagener syndrome

Cell Membrane

  • Fluid mosaic model: phospholipid bilayer with embedded proteins
  • Hydrophilic heads face outward; hydrophobic tails face inward
  • Cholesterol - stabilizes membrane fluidity
  • Glycoproteins/glycolipids - cell recognition, blood group antigens

Cell Cycle

G1 → S (DNA synthesis) → G2 → M (Mitosis)
         ↑ Cyclin-CDK checkpoints
  • G1/S checkpoint - regulated by cyclin D/CDK4,6 → phosphorylates Rb → releases E2F
  • G2/M checkpoint - cyclin B/CDK1
  • p53 - "guardian of the genome"; activates p21 (CDK inhibitor) → cell cycle arrest
  • Rb gene - tumor suppressor; mutation → retinoblastoma, osteosarcoma

Cell Signaling (important types)

Receptor TypeLigandsMechanism
GPCREpinephrine, glucagon, TSHAdenylyl cyclase → cAMP → PKA
RTKInsulin, growth factorsAutophosphorylation → Ras → MAPK
Nuclear receptorsSteroids, thyroid hormoneDirectly bind DNA response elements
Ion channelsACh (nicotinic)Direct ion flow

4. CARBOHYDRATES

Glycolysis (Cytoplasm)

  • Glucose (6C) → 2 Pyruvate (3C)
  • Net yield: 2 ATP + 2 NADH (anaerobic: 2 lactate)
  • Key regulatory enzymes:
    1. Hexokinase/Glucokinase - step 1 (Glucokinase in liver: high Km, induced by insulin)
    2. Phosphofructokinase-1 (PFK-1) - rate-limiting step; inhibited by ATP, citrate; activated by AMP, fructose-2,6-bisphosphate
    3. Pyruvate kinase - final step

Pyruvate Dehydrogenase Complex (PDC)

  • Pyruvate → Acetyl-CoA (irreversible, in mitochondria)
  • Requires: B1 (TPP), B2 (FAD), B3 (NAD+), B5 (CoA), Lipoic acid
  • Mnemonic: "Tender Loving Care For Nerves" (TPP, Lipoate, CoA, FAD, NAD+)
  • PDC deficiency → lactic acidosis, neurological problems

TCA Cycle (Krebs Cycle) - Mitochondria

  • Acetyl-CoA (2C) + OAA (4C) → Citrate (6C) → ... → OAA
  • Yield per turn: 3 NADH + 1 FADH2 + 1 GTP + 2 CO2
  • Rate-limiting enzyme: Isocitrate dehydrogenase
  • Key enzymes: Citrate synthase, Isocitrate DH, α-KG DH, Succinate DH (only membrane-bound; FADH2)

Electron Transport Chain (ETC) + Oxidative Phosphorylation

  • Located in inner mitochondrial membrane
  • Complex I (NADH → CoQ), II (FADH2 → CoQ), III (CoQ → Cyt c), IV (Cyt c → O2)
  • ATP synthase (Complex V) - uses proton gradient (chemiosmosis)
  • Yield: NADH = 2.5 ATP; FADH2 = 1.5 ATP
  • Total glucose oxidation: ~30-32 ATP
ETC Inhibitors:
AgentBlocks
RotenoneComplex I
Antimycin AComplex III
Cyanide, COComplex IV
OligomycinATP synthase
DinitrophenolUncoupler (↑ heat, ↓ ATP)

Gluconeogenesis

  • Glucose synthesis from non-carbohydrate precursors (lactate, glycerol, amino acids - especially alanine)
  • Primarily in liver (also kidney in fasting)
  • Bypasses 3 irreversible glycolysis steps using:
    1. Pyruvate carboxylase → OAA (requires biotin)
    2. PEPCK → PEP
    3. Fructose-1,6-bisphosphatase
    4. Glucose-6-phosphatase (liver only)

Glycogen Metabolism

ProcessEnzymeRegulated by
SynthesisGlycogen synthaseInsulin (activates), glucagon/epinephrine (inactivate)
BreakdownGlycogen phosphorylaseGlucagon, epinephrine (activate)
Glycogen storage diseases:
DiseaseEnzyme defectOrganKey feature
Von Gierke (Ia)Glucose-6-phosphataseLiver, kidneyFasting hypoglycemia, hepatomegaly
Pompe (II)Acid maltase (α-1,4-glucosidase)Heart, muscleCardiomegaly, hypotonia
Cori (III)Debranching enzymeLiver, muscleMild Von Gierke-like
McArdle (V)Muscle phosphorylaseMuscleCramps, no lactate rise with exercise

HMP Shunt (Pentose Phosphate Pathway)

  • In cytoplasm; no ATP production
  • Products: NADPH (for anabolic reactions and oxidative burst), Ribose-5-phosphate (nucleotide synthesis)
  • Rate-limiting: Glucose-6-phosphate dehydrogenase (G6PD)
  • G6PD deficiency → hemolytic anemia with oxidant stress (primaquine, fava beans)

Blood Glucose Regulation

HormoneBlood glucoseKey action
Insulin↑ GLUT4 in muscle/fat; ↑ glycolysis, glycogenesis; ↓ gluconeogenesis
Glucagon↑ glycogenolysis, gluconeogenesis (liver only)
Epinephrine↑ glycogenolysis (muscle + liver)
Cortisol↑ gluconeogenesis; insulin resistance

5. AMINO ACIDS & METABOLISM

Essential Amino Acids (10)

"PVT TIM HaLL" - Phenylalanine, Valine, Tryptophan, Threonine, Isoleucine, Methionine, Histidine, Arginine (conditionally), Leucine, Lysine

Amino Acid Structure

  • All have: α-amino group, α-carboxyl group, H, and R (side chain)
  • Amphoteric - act as acid and base (zwitterion at physiological pH)
  • At pI (isoelectric point): net charge = 0

Transamination

  • Transfer of amino group from amino acid to α-ketoacid
  • Key enzyme: Aminotransferases (require PLP/B6)
  • ALT (alanine transaminase) - liver-specific
  • AST (aspartate transaminase) - liver + heart

Urea Cycle (liver mitochondria + cytoplasm)

Ammonia is toxic → converted to urea for excretion
Steps: NH3 + CO2 → Carbamoyl phosphate → Citrulline → Argininosuccinate → Arginine → Urea + Ornithine
Rate-limiting: Carbamoyl phosphate synthetase I (CPS-I)
  • Activated by N-acetylglutamate (NAG)
  • NAG synthesis activated by arginine
Urea cycle disorders: hyperammonemia → encephalopathy, intellectual disability
Enzyme defectAccumulates
CPS-IAmmonia only
OTC (ornithine transcarbamylase)Ammonia + orotic acid (most common X-linked)
Arginosuccinate synthetase (Citrullinemia)Citrulline
Arginosuccinate lyaseArgininosuccinate
ArginaseArginine

Key Amino Acid Disorders

DisorderEnzyme DefectKey Findings
PKUPhenylalanine hydroxylase (or BH4)Musty odor, intellectual disability, fair skin, eczema
AlkaptonuriaHomogentisate oxidaseDark urine, ochronosis, arthritis
Maple Syrup Urine DiseaseBranched-chain α-keto acid DHSweet urine, neurological damage; restrict Leu, Ile, Val
HomocystinuriaCystathionine synthase (or B12/folate deficiency)Lens subluxation (down), Marfanoid, DVT, intellectual disability
AlbinismTyrosinaseNo melanin, photosensitivity
Hartnup diseaseTryptophan transporter (neutral amino acids)Pellagra-like rash, ataxia

One-Carbon Metabolism

  • Folate (THF) + B12 carry one-carbon units
  • Methionine synthase: Homocysteine + CH3-THF → Methionine + THF (needs B12)
  • Folate deficiency → megaloblastic anemia, neural tube defects
  • B12 deficiency → megaloblastic anemia + subacute combined degeneration of spinal cord
  • Methylmalonic acid ↑ in B12 deficiency only (distinguishes from folate deficiency)

Heme Synthesis & Porphyrias

  • ALA synthase (rate-limiting; mitochondria) - requires B6
  • Porphobilinogen → Uroporphyrinogen → Coproporphyrinogen → Heme
PorphyriaEnzyme defectKey features
AIP (Acute Intermittent)PBG deaminase5 Ps: Pain (abdomen), Port-wine urine, Polyneuropathy, Psychological, Precipitated by drugs
PCT (Porphyria Cutanea Tarda)Uroporphyrinogen decarboxylasePhotosensitive blistering, most common porphyria
Lead poisoningALA dehydratase + FerrochelataseBasophilic stippling, ↑ ALA, ↑ ZnPP

6. LIPIDS

Fatty Acid Synthesis (Cytoplasm)

  • Glucose → Acetyl-CoA → Malonyl-CoA → Palmitate (16C)
  • Rate-limiting enzyme: Acetyl-CoA Carboxylase (ACC); requires biotin
  • Activated by insulin and citrate; inhibited by glucagon, epinephrine, palmitoyl-CoA
  • Fatty acid synthase (FAS) is a multifunctional enzyme

Beta-Oxidation (Mitochondria)

  • Breaks down fatty acids → Acetyl-CoA
  • Entry requires carnitine shuttle (long-chain FA cannot enter directly)
    • Carnitine palmitoyltransferase I (CPT-I) - rate-limiting; inhibited by malonyl-CoA
  • Each cycle removes 2 carbons as Acetyl-CoA
  • Yield per cycle: 1 NADH + 1 FADH2 + 1 Acetyl-CoA
Odd-chain FA → final product is propionyl-CoA → methylmalonyl-CoA → succinyl-CoA (requires B12)

Ketone Bodies

  • Produced in liver mitochondria during prolonged fasting, starvation, DKA
  • Acetoacetate, β-hydroxybutyrate, acetone
  • Cannot be used by liver (lacks thiophorase/succinyl-CoA acetoacetyl transferase)
  • Used by brain, heart, skeletal muscle, kidney cortex
In DKA: ketones ↑, metabolic acidosis, fruity breath (acetone)

Cholesterol Metabolism

  • Synthesized in liver from Acetyl-CoA (cytoplasm)
  • Rate-limiting enzyme: HMG-CoA reductase (target of statins)
  • Cholesterol → bile acids (bile salt synthesis), steroid hormones, Vitamin D, cell membranes

Lipoproteins

LipoproteinMade inCarries mainlyKey protein
ChylomicronsIntestineDietary TGsApoB-48
VLDLLiverEndogenous TGsApoB-100
IDLFrom VLDLTGs + CholesterolApoB-100, ApoE
LDLFrom IDLCholesterol ("bad")ApoB-100
HDLLiver/intestineReverse cholesterol transportApoA-I
Key Apoproteins:
  • ApoC-II - activates lipoprotein lipase (LPL)
  • ApoE - receptor binding; ApoE4 → ↑ Alzheimer's risk
  • ApoB-100 - LDL receptor binding

Phospholipids & Sphingolipids

LipidKey role
Phosphatidylcholine (lecithin)Major membrane component, lung surfactant
PhosphatidylinositolSecond messenger precursor (DAG, IP3)
SphingomyelinMyelin sheath
CerebrosideBrain glycolipids
GangliosidesNeuronal signaling

Sphingolipidoses

DiseaseEnzyme DefectAccumulatesKey Feature
Gaucher'sGlucocerebrosidaseGlucocerebrosideHepatosplenomegaly, "Crinkled paper" cells, bone pain; most common
Niemann-PickSphingomyelinaseSphingomyelinHSM, cherry-red macula, "foamy" cells
Tay-SachsHexosaminidase AGM2 gangliosideCherry-red macula, NO hepatosplenomegaly
Fabry'sα-Galactosidase AGlobotriaosylceramideAngiokeratomas, renal failure, X-linked
Krabbe'sGalactocerebrosidaseGalactocerebrosidePeripheral neuropathy, globoid cells
Metachromatic leukodystrophyArylsulfatase ACerebroside sulfateDemyelination, ataxia
Mnemonic for Tay-Sachs vs Niemann-Pick: Tay-Sachs = No Spleen; Niemann-Pick = Pick up the spleen

Quick-Reference: High-Yield MBBS Biochemistry Facts

TopicMost Asked
EnzymologyKm/Vmax, competitive vs non-competitive inhibition, isoenzymes in MI
Molecular BiologyDNA replication enzymes, antibiotic ribosome targets, mutations
CellsOrganelle functions, cytoskeleton disorders, cell cycle checkpoints
CarbohydratesPFK-1 regulation, PDC cofactors, glycogen storage diseases, ETC inhibitors
Amino AcidsPKU, homocystinuria, urea cycle (OTC deficiency), porphyrias
LipidsACC (rate-limiting synthesis), CPT-1 (rate-limiting β-oxidation), statins, sphingolipidoses

These notes cover the highest-yield examinable material for MBBS university biochemistry. Focus especially on:
  1. Enzyme kinetics graphs (Lineweaver-Burk)
  2. Glycogen storage diseases and sphingolipidoses (frequently asked as clinical vignettes)
  3. Urea cycle enzyme defects and distinguishing features
  4. Vitamin-coenzyme pairings and their deficiency diseases
  5. Isoenzymes in disease (LDH, CK, ALP)
This is a shared conversation. Sign in to Orris to start your own chat.